For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241104:nRSD7858Ka&default-theme=true
RNS Number : 7858K Spire Healthcare Group PLC 04 November 2024
4 November 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 1 November 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 220.50
Lowest price paid per Share (GBp): 215.75
Volume weighted average price paid per Share (GBp): 217.6636
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 404,088,352. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 404,088,352.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price (GBp share) Time of transaction (UK Time) Transaction reference number Trading venue
1 November 2024 115 216.00 09:37:09 00072180336TRLO0 XLON
1 November 2024 357 216.00 09:37:09 00072180335TRLO0 XLON
1 November 2024 399 216.00 09:37:47 00072180342TRLO0 XLON
1 November 2024 46 216.00 09:37:47 00072180343TRLO0 XLON
1 November 2024 20000 215.75 09:37:55 00072180346TRLO0 XLON
1 November 2024 2097 216.50 10:36:03 00072182443TRLO0 XLON
1 November 2024 1789 218.50 10:46:46 00072182919TRLO0 XLON
1 November 2024 277 218.50 10:46:46 00072182920TRLO0 XLON
1 November 2024 277 218.50 10:46:46 00072182921TRLO0 XLON
1 November 2024 1800 218.50 10:46:46 00072182922TRLO0 XLON
1 November 2024 371 218.50 10:46:46 00072182923TRLO0 XLON
1 November 2024 452 219.00 10:52:57 00072183052TRLO0 XLON
1 November 2024 218 219.00 10:52:57 00072183053TRLO0 XLON
1 November 2024 519 219.00 10:52:57 00072183054TRLO0 XLON
1 November 2024 2318 218.00 11:00:54 00072183301TRLO0 XLON
1 November 2024 741 219.00 11:49:47 00072186039TRLO0 XLON
1 November 2024 450 219.00 11:49:47 00072186040TRLO0 XLON
1 November 2024 500 219.00 11:49:47 00072186041TRLO0 XLON
1 November 2024 4200 219.50 13:18:03 00072188768TRLO0 XLON
1 November 2024 2236 219.50 13:48:48 00072190407TRLO0 XLON
1 November 2024 2007 219.50 15:08:39 00072194489TRLO0 XLON
1 November 2024 1163 219.00 15:15:48 00072194934TRLO0 XLON
1 November 2024 450 220.50 15:39:57 00072196007TRLO0 XLON
1 November 2024 514 220.50 15:39:57 00072196008TRLO0 XLON
1 November 2024 2026 220.00 15:40:22 00072196028TRLO0 XLON
1 November 2024 1115 219.50 16:05:42 00072197208TRLO0 XLON
1 November 2024 939 219.50 16:05:42 00072197209TRLO0 XLON
1 November 2024 1194 219.50 16:05:42 00072197210TRLO0 XLON
1 November 2024 1430 220.00 16:09:37 00072197421TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSDZLBBZFLLFBX